News & Updates

Is T1D protective against Parkinson’s disease?

24 Jun 2024 by

Researchers from Singapore found an association between type 1 diabetes (T1D) and Parkinson’s disease (PD) in a Mendelian randomization (MR) study.

Is T1D protective against Parkinson’s disease?

24 Jun 2024

Migraine diagnosis in primary care: How?

21 Jun 2024

Optimal management of migraine requires prompt diagnosis in the primary care setting. This article highlights recommendations on migraine diagnosis endorsed by the European Headache Federation (EHF) and European Academy of Neurology (EAN), which are applicable to settings including primary care.

Migraine diagnosis in primary care: How?

21 Jun 2024

Extending givosiran use may help non–attack-free AHP patients achieve attack-free status

20 Jun 2024 by

Patients with AHP who do not achieve an attack-free status after the first 6 months of givosiran treatment can still benefit from further attack reductions and QoL improvements with continued treatment up to 36 months, according to the results from the ENVISION trial presented at EASL 2024

Extending givosiran use may help non–attack-free AHP patients achieve attack-free status

20 Jun 2024

Early diagnosis and management of AL amyloidosis: An underdiagnosed multiorgan disease

19 Jun 2024 by

Light-chain (AL) amyloidosis is a progressive, underdiagnosed disease with multiorgan involvement, most notably of the heart, kidneys, and liver. Nearly half of the patients consult ≥4 physicians before receiving correct diagnosis. At the Hong Kong Society of Haematology Annual Scientific Meeting (HKSH ASM) 2024, Professor Morie Gertz of the Mayo Clinic, Minnesota, US, shared insights into establishing an early and accurate diagnosis and discussed the ANDROMEDA trial, which led to the first US FDA–approved treatment – daratumumab in combination with bortezomib, cyclophosphamide, and dexamethasone (D-VCd).

Early diagnosis and management of AL amyloidosis: An underdiagnosed multiorgan disease

19 Jun 2024

Simplified questionnaire aims to improve early PN diagnosis

18 Jun 2024 by

Early recognition of peripheral neuropathy (PN) is crucial to prevent or delay disease progression and development of associated complications. In an interview with MIMS Doctor, Dr Vivien Lim, Specialist in Endocrinology at the Gleneagles Medical Centre in Singapore, discussed potential reasons for delayed PN diagnosis, particularly in patients with diabetes mellitus (DM). She also introduced a simple questionnaire developed by a panel of neurologists and endocrinologists for both patients and physicians, to urge early detection of PN in the primary care setting.

Simplified questionnaire aims to improve early PN diagnosis

18 Jun 2024

Reduced-dose DOACs tied to lower stroke incidence vs warfarin

10 Jun 2024

Patients with atrial fibrillation receiving a reduced dose of direct acting oral anticoagulants (DOAC), particularly rivaroxaban and dabigatran, show a similar incidence of ischaemic stroke and systemic embolism to those receiving warfarin, a study has shown.

Reduced-dose DOACs tied to lower stroke incidence vs warfarin

10 Jun 2024

CXCL13 in cerebrospinal fluid aids in neurosyphilis diagnosis

09 Jun 2024

Evaluation of CXCL13 concentration in cerebrospinal fluid (CSF) shows good diagnostic accuracy for neurosyphilis, according to the results of a systematic review and meta-analysis.

CXCL13 in cerebrospinal fluid aids in neurosyphilis diagnosis

09 Jun 2024

High cognitive reserve may counter dementia risk

07 Jun 2024 by

High cognitive reserve appears to confer protection against dementia, even among people with genetic predisposition to dementia, according to a study.

High cognitive reserve may counter dementia risk

07 Jun 2024

Increased practice of Chinese calligraphy strengthens brain network in older adults

07 Jun 2024 by

Increased practice of Chinese calligraphy strengthens brain network in older individuals who already practice the cognitive activity regularly and experienced subjective cognitive decline (SCD), a two-arm, parallel-design, assessor-blind, randomized controlled trial conducted by the Chinese University of Hong Kong (CUHK) has found.

Increased practice of Chinese calligraphy strengthens brain network in older adults

07 Jun 2024

COVID-19 does mess with the brain even years after infection

06 Jun 2024 by

A long-term study showed that individuals who have recovered from COVID-19 continued to experience cognitive, psychiatric, and neurological issues, as well as brain functional alteration, even 2 years after being infected.

COVID-19 does mess with the brain even years after infection

06 Jun 2024

News & Updates

Filter by Specialty:

Specialty:

Is T1D protective against Parkinson’s disease?

Is T1D protective against Parkinson’s disease?

Migraine diagnosis in primary care: How?

Migraine diagnosis in primary care: How?

Extending givosiran use may help non–attack-free AHP patients achieve attack-free status

Extending givosiran use may help non–attack-free AHP patients achieve attack-free status

Early diagnosis and management of AL amyloidosis: An underdiagnosed multiorgan disease

Early diagnosis and management of AL amyloidosis: An underdiagnosed multiorgan disease

Simplified questionnaire aims to improve early PN diagnosis

Simplified questionnaire aims to improve early PN diagnosis

Reduced-dose DOACs tied to lower stroke incidence vs warfarin

Reduced-dose DOACs tied to lower stroke incidence vs warfarin

CXCL13 in cerebrospinal fluid aids in neurosyphilis diagnosis

CXCL13 in cerebrospinal fluid aids in neurosyphilis diagnosis

High cognitive reserve may counter dementia risk

High cognitive reserve may counter dementia risk

Increased practice of Chinese calligraphy strengthens brain network in older adults

Increased practice of Chinese calligraphy strengthens brain network in older adults

COVID-19 does mess with the brain even years after infection

COVID-19 does mess with the brain even years after infection